Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-25-012305
Filing Date
2025-04-04
Accepted
2025-04-04 16:05:40
Documents
18
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20041152x1_def14a.htm   iXBRL DEF 14A 856393
3 ny20041152x1_pvp01.jpg GRAPHIC 248090
4 ny20041152x1_pvp02.jpg GRAPHIC 237170
5 sig_lindsayandroski.jpg GRAPHIC 20463
6 ny20041152x1_pc01.jpg GRAPHIC 690171
7 ny20041152x1_pc02.jpg GRAPHIC 597276
  Complete submission text file 0001140361-25-012305.txt   6176984

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA abus-20250521.xsd EX-101.SCH 2133
20 EXTRACTED XBRL INSTANCE DOCUMENT ny20041152x1_def14a_htm.xml XML 200041
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34949 | Film No.: 25813987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)